- Home
- Programs and Groups
- Shared Resources
- Faculty
- Clinical Trials
- Tumor Registry
- Education
- About DCI
Quick Links
Pediatric Clinical Trials - Pediatric Neuroblastoma
If you would like to inquire about all open trials, please contact 919-684-3401.
Items 1 - 3 of 3
Items 1 - 3 of 3
A Comparative Pharmacokinetic and Safety Study of Chimeric Monoclonal Antibody ch14.18 with Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2 (IL-2) and Isotretinoin in High Risk Neuroblastoma Patients Following Myeloablative Therapy (IND 110,494)
DIV-NB-201
Principal Investigator: Michael Armstrong
Phase: N/A
Phone: 919-684-3401
Principal Investigator: Michael Armstrong
Phase: N/A
Phone: 919-684-3401
An Open Label, Expanded Access Protocol Using (131)I-Metaiodobenzylguanidine (I-MIBG) Therapy in Patients with Refractory Neuroblastoma
Principal Investigator: Michael Armstrong
Phase: Other
Phone: 919-684-3401
Principal Investigator: Michael Armstrong
Phase: Other
Phone: 919-684-3401
NANT1999-02 Modulation of Intensive Melphalan (L-PAM) by Buthionine Sulfoximine (BSO) with Autologous Stem Cell Support for Resistant/Recurrent High-Risk Neuroblastoma (IND#69,112)
Principal Investigator: Michael Armstrong
Phase: Phase I
Phone: 919-684-3401
Principal Investigator: Michael Armstrong
Phase: Phase I
Phone: 919-684-3401
